 Provider News CaliforniaAugust 1, 2024 August 2024 Provider Newsletter Featured Articles Policy Updates | Medicaid | July 19, 2024
Beginning with claims processing on or after August 31, 2024, Anthem will implement revised claims editing logic tied to Excludes1 notes from ICD-10-CM 2020 coding guidelines. To help ensure the accurate processing of claims, care providers are encouraged to use ICD-10-CM coding guidelines when selecting the most appropriate diagnosis for member encounters. Please remember to code to the highest level of specificity. For example, if there is an indication at the category level that a code can be billed with another range of codes, it is imperative to look for Excludes1 notes that may prohibit billing a specific code combination. The concept of Excludes1 notes is one of the unique attributes of the ICD-10-CM code set and coding conventions. An Excludes1 note indicates that the excluded code identified in the note should not be billed with the code or code range listed above the Excludes1 note. These notes appear below the affected codes; if the note appears under the category (the first three characters of a code), it applies to the entire series of codes within that category. If the Excludes1 note appears beneath a specific code (three, four, five, six, or seven characters in length) then it applies only to that specific code. In ICD-10-CM, when a category includes an Excludes1 note, it outlines what codes should not be billed together. Examples of this code scenario would include but are not limited to the following: - Reporting Z01.419 with Z12.4:
- 41X (encounter GYN exam w/out abnormal findings) has an Excludes1 note below that includes Z12.4 (encounter for screening malignant neoplasm cervix).
- Reporting Z79.891with F11.2X:
- 891 (long-term use of opiates) has an Excludes1 note after it for F11.2X (opioid dependence).
- Reporting M54.2 with M50.XX:
- 2 (cervicalgia) has an Excludes1 note below it for M50.XX (cervicalgia due to intervertebral disc disorder).
- Reporting M54.5 with S39.012X and/or M54.4x:
- 5 (low back pain) has an Excludes1 note below it, which includes S93.012X (strain of muscle, fascia and tendon of lower back), M54.4X (low back pain), and M51.2X (lumbago due to intervertebral disc disorder).
- Reporting J03.XX with J02.XX, J35.1, J36, J02.9:
- Acute tonsillitis has an Excludes1 note below it, which includes J02.- (acute sore throat), J35.1 (hypertrophy of tonsils), and J36 (peritonsillar abscess).
- Reporting N89 with R87.62X, D07.2, R87.623, N76.XX, N95.2N89 (other inflammatory disorders of the vagina) has an Excludes1 note below the category for R87.62X (abnormal results from vaginal cytological exam), D07.2 (vaginal intraepithelial neoplasia), R87.623 (HGSIL of vagina), N76.XX inflammation of the vagina), N95.2 (senile [atrophic] vaginitis), and A59.00 (trichomonal leukorrhea).
Finally, if you believe an Excludes1 note denial is incorrect, please consult the ICD-10-CM code book to verify appropriate use of the billed codes and provide supporting documentation through the normal dispute process to indicate why the billed diagnoses codes are appropriately used together. If you have questions about this communication or need assistance with any other item, contact your provider relationship management representative. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-063304-24-CPN63181 Beginning with claims processing on or after September 1, 2024, Anthem will update their claims editing process for professional claims to support mutually exclusive places of service edits. According to CMS policy, the place of service (POS) code used should indicate the setting in which the patient received a face-to-face encounter or where the technical component of a service was rendered in the case of an interpretation. However, when a patient is in a registered inpatient status, all services billed by all providers should reflect and acknowledge the patient's inpatient status. A physician/practitioner/supplier furnishing services to a patient who is a registered inpatient shall, at a minimum, report the inpatient hospital POS code 21 irrespective of the setting where the patient receives the face-to-face encounter. For additional information, please visit CMS.gov: If you have questions about this communication or need assistance with any other item, contact your provider relationship management representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-061212-24-CPN61079 Please review your online provider directory information on a regular basis to ensure that it’s correct. Access your online provider directory information by visiting our California provider homepage. At the top, select Find Care. Review your information and let us know if any of your directory information has changed. Updating your informationAnthem uses the Provider Data Management (PDM) application in Availity Essentials to update your care provider or facility data. Using Availity’s PDM capability meets the quarterly attestation requirement to validate care provider demographic data set by the Consolidated Appropriations Act (CAA). PDM features include:- Updating care provider demographic information for all assigned payers in one location.
- Attesting to and managing current care provider demographic information using directory verification or roster submission.
- Monitoring submitted demographic updates in real-time with a digital dashboard when roster option is used.
- Reviewing the history of previously verified data.
Accessing the PDM applicationTo begin using PDM, log on to Availity and select My Providers > Provider Data Management. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information. PDM training is availableFrom the Availity Essentials homepage, go to Help & Training > Find Help to locate articles and step-by-step guides. Search for provider data management and select the resulting link. Listen to the recording of our roster automation template and rules of engagement training (on24.com) on our provider learning hub. Not registered for Availity yet?If you aren’t registered to use Availity Essentials, signing up is easy and secure. There is no cost for care providers to register or to use any of our digital applications. Start by going to Availity > New to Availity > Get Started at the top of the homepage to access the registration page. If you have more than one tax ID number (TIN), please ensure that you have registered all TINs associated with your account. If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY (800-282-4548). Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-062945-24 As a reminder, effective October 1, 2024, Carelon Medical Benefits Management will expand multiple programs to perform medical necessity reviews for additional procedures for Anthem members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable. The continued migration will expand clinical appropriateness review for procedures related to the following existing Carelon Medical Benefits Management programs: cardiovascular, musculoskeletal, radiation oncology, radiology, sleep, and surgical. In addition, some codes will migrate into a new Carelon Medical Benefits Management solution — additional outpatient utilization management (UM) that will include some transportation (including ambulance) and fertility procedures as set forth below. Transportation may include emergency post-service reviews. The Clinical UM Guidelines and Medical Policies by Anthem for medical necessity review are listed in the table below. Carelon Medical Benefits Management will begin accepting prior authorization requests on September 23, 2024, for dates of service on or after October 1, 2024. Members included in the new program Updates to Carelon Medical Benefits Management programs apply to select local fully insured Anthem members and select members who are covered under self-insured (ASO) benefit plans with services medically managed by Carelon Medical Benefits Management. This notice does not apply to certain HMO, BlueCard®, Medicare Advantage, Medicaid, Medicare Supplemental, or Federal Employee Program® (FEP®). For more information, please contact the phone number on the back of the member ID card. Pre-service review requirements For procedures that are scheduled to begin on or after October 1, 2024, all care providers must contact Carelon Medical Benefits Management to obtain pre-service review for the services including, but not limited to, the following non-emergency modalities. Please refer to the Clinical Guidelines at anthem.com/ca/provider > Providers > Provider Resources > Policies, Guidelines & Manuals for complete code lists. Note: All codes will be reviewed for medical necessity for the requested service and not for site of care. Please note some services below are effective March 1, 2025. Program | Services | Medical Policies or Clinical Guidelines | Cardiovascular | - Intracardiac ischemia monitoring
- OP cardiac hemodynamic monitoring w/wireless sensor for heart failure management
- Non-invasive heart failure and arrhythmia monitoring system
| - MED.00111
- MED.00115
- MED.00134
| Musculoskeletal | - US bone growth stim
- Manipulation under anesthesia
- Anesthesia for interventional pain procedures
- Facet joint allograft implants for facet disease
- Electrothermal shrinkage of joint capsules, ligaments, and tendons
- Implant of nerve stim. devices
- Radiofrequency neurolysis and pulsed radiofrequency therapy for trigeminal neuralgia
| - CG-DME-45
- CG-MED-65
- SURG.00043
- CG-MED-78
- CG-SURG-08
- CG-SURG-89
- SURG.00114
| Radiology | - Magnetic source imaging and magnetoencephalography
- Dynamic spinal visualization (including digital motion X-ray and cineradiography/ videofluoroscopy)
- Cervical and thoracic discography
| - CG-MED-76
- RAD.00034
- RAD.00053
| Radiation oncology | - Neutron beam radiotherapy
| | Sleep | - Electronic positional devices for Tx of OSA
- Neuromuscular electrical training for Tx of OSA
| | Surgical GI | - High resolution anoscopy screening
- Doppler-guided transanal hemorrhoidal de-arterialization
| |
Update to previous notice: The services additional outpatient utilization management and base surgical below are effective March 1, 2025. Program | Services | Medical Policies or Clinical Guidelines | Additional outpatient utilization management services (effective 3/1/2025) | - Fertility
- Therapeutic apheresis
- Hyperbaric oxygen therapy
- Physiologic record of tremor
- Home parenteral nutrition
- Imaging evaluation of skin lesions
- Ambulance services (not applicable to Connecticut)
- Virtual reality-assisted therapy systems
- Quantitative sensory testing
- Automated nerve conduction testing
- Bioimpedance spectroscopy
- Autonomic testing
- Continuous monitoring of intraocular pressure
- Seizure monitoring
- Electronic home visual field monitoring
- Eye movement analysis for diagnosis of concussion
- High-volume colonic irrigation
- Electrical stimulation as a treatment for pain
and other conditions - Sensory stimulation for brain-injured individuals in coma or vegetative state
- Automated evacuation of meibomian gland
- Selected sleep testing
| - CG-MED-68
- MED.00101
- CG-MED-89
- CG-MED-73
- CG-MED-73
- DME.00011
- DME.00048
- MED.00011
- MED.00082
- MED.00092
- MED.00103
- MED.00105
- MED.00112
- MED.00118
- MED.00130
- MED.00131
- MED.00137
- MED.00141
- MED.00002
- MED.00004
- CG-MED-66
- CG-MED-88
- CG-SURG-35
- LAB.00045
- CG-ANC-04
- CG-ANC-06
| Cardiovascular services effective 3/1/2025 | - Intravascular stent
- Angioplasty
- Central venous access device
- Sclerotherapy
- Endovenous therapy
- Vascular embolization/occlusion organ/venous
- Echosclerotherapy
- Balloon dilatation
- Balloon angioplasty
- Transcath stent
- Dialysis circuit with angiography
- Carotid sinus procedures
- Carotid sinus neurostimulator
| - CG-SURG-106
- CG-SURG-119
- CG-SURG-28
- CG-SURG-76
- CG-SURG-83
- CG-SURG-93
- RAD.00059
- SURG.00062
- SURG.00124
| Base surgical effective 3/1/2025 | - Anesthesia for dental services
- Skin-related cosmetic and reconstructive services
- Balloon dilation of eustachian tubes
- Functional endoscopic sinus surgery
- Bronchial thermoplasty
- Balloon sinus ostial dilation
- Cochlear and auditory brainstem implants
- Implantable hearing aids
- Surgical treatment for obstructive sleep apnea and snoring
- Drug-eluting devices to maintain sinus ostial patency
- Minimally invasive treatment of posterior nasal nerve for rhinitis
- MRI guided high-intensity focused ultrasound ablation for non-oncologic indications
- Uterine fibroid ablation
- Sacral nerve stimulation as a treatment of neurogenic bladder secondary to spinal cord injury
- Vagus nerve stimulation
- Ablation for solid tumors outside the liver
- Irreversible electroporation
- Corneal collagen cross linking
- Intraocular telescope
- Automated evacuation of meibomian gland
- Presbyopia and astigmatism-correcting intraocular lenses
- Viscocanalostomy and canaloplasty
- Intraocular anterior segment aqueous drainage devices
- Implanted artificial iris devices
- Implanted port delivery systems for ocular disease
- Implantable infusion pumps
- Treatments for urinary and fecal incontinence, urinary retention
- Reduction mammaplasty
- Mastectomy for gynecomastia
- Panniculectomy and abdominoplasty
- Adipose-derived regenerative cell therapy and soft tissue augmentation
- Products for wound healing and soft tissue grafting
- Surgical and ablative treatments for chronic headaches
- Intraoperative assessment of surgical margins during breast-conserving surgery with radiofrequency spectroscopy or optical coherence tomography
- Mandibular/maxillary surgery
- Blepharoplasty, repair, and brow lift
- Internal rib fixation systems
- Prostate saturation biopsy
- Focal laser ablation for the treatment of prostate cancer
- Penile prosthesis implantation
- Diaphragmatic/phrenic nerve stimulation and pacing systems
- High intensity focused ultrasound ablation for oncologic indications
- Renal sympathetic nerve ablation
- Hysterectomy
- Laparoscopic gynecologic surgery
- Myomectomy
- Transurethral destruction, prostate tissue
- Temporomandibular disorders (SURG-09)
- Septoplasty (SURG-18)
- Bariatric surgery and other treatment for clinically severe obesity (SURG-81)
- Nasal valve repair (SURG.00079)
- Bone-anchored and bone conduction hearing aids (SURG-82)
| - ANC.00007
- CG-MED-41
- CG-MED-79
- CG-MED-81
- CG-SURG-03
- CG-SURG-08
- CG-SURG-09
- CG-SURG-105
- CG-SURG-12
- CG-SURG-117
- CG-SURG-118
- CG-SURG-120
- CG-SURG-18
- CG-SURG-24
- CG-SURG-61
- CG-SURG-71
- CG-SURG-73
- CG-SURG-79
- CG-SURG-81
- CG-SURG-82
- CG-SURG-83
- CG-SURG-84
- CG-SURG-88
- CG-SURG-95
- CG-SURG-96
- CG-SURG-99
- MED.00057
- MED.00103
- MED.00132
- SURG.00010
- SURG.00011
- SURG.00118
- SURG.00061
- SURG.00077
- SURG.00079
- SURG.00084
- SURG.00095
- SURG.00096
- SURG.00107
- SURG.00116
- SURG.00120
- SURG.00126
- SURG.00129
- SURG.00132
- SURG.00135
- SURG.00139
- SURG.00141
- SURG.00156
- SURG.00157
- SURG.00159
- SURG.00160
- MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
- MCG: ISC: S-450/450-RRG/5450: Laparotomy for Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy
- MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
- MCG: ISC: S-665/665-RRG: Hysterectomy, Laparoscopic
- MCG: ISC: S-775/775-RRG: Laparoscopic Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy
|
To determine if prior authorization is needed for a member on or after October 1, 2024, contact the Provider Services phone number on the back of the member’s ID card for benefit information. Care providers using the Interactive Care Reviewer (ICR) tool on Availity.com to pre-certify an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management. (Note: ICR cannot accept prior authorization requests for services administered by Carelon Medical Benefits Management.) Care providers should continue to submit pre-service review requests to Carelon Medical Benefits Management using the convenient online service via the Carelon Medical Benefits Management provider portal. The provider portal is available 24 hours a day, seven days a week, processing requests in real-time using Clinical Criteria. Go to providerportal.com to register. For more information For resources to help your practice get started with the cardiology, musculoskeletal, radiology, sleep, surgical procedures, and radiation oncology programs, visit: Our website at anthem.com/ca/provider helps you access information and tools such as order entry checklists, Clinical Guidelines, and FAQ. You can also contact your local network relations representative if you have any questions. Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-063150-24-CPN62856 Effective October 1, 2024, Carelon Medical Benefits Management, Inc. will expand multiple programs to perform medical necessity reviews for additional procedures for Anthem members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable. The expansion will require clinical appropriateness review for additional procedures related to Carelon Medical Benefits Management programs, including cardiology, radiation oncology, radiology, musculoskeletal, sleep, surgical, and additional outpatient services. Carelon Medical Benefits Management will follow the clinical hierarchy established by Anthem for medical necessity determination. Anthem makes coverage determinations based on CMS guidance, including national coverage determinations (NCDs), local coverage determinations (LCDs), other coverage guidelines and instructions issued by CMS, and legislative changes in benefits. When existing guidance does not provide sufficient clinical detail, Carelon Medical Benefits Management will determine medical necessity using an objective, evidence-based process. Carelon Medical Benefits Management will continue to use criteria documented in the Medical Policies and Clinical Guidelines of Anthem listed in the table below. These Clinical Guidelines can be found at Availity.com. Detailed prior authorization (PA) requirements are available online by accessing the Precertification Lookup Tool under Payer Spaces at Availity.com. Contracted and noncontracted care providers should call Provider Services at the phone number on the back of the member’s ID card for PA requirements. Prior authorization review requirementsCarelon Medical Benefits Management will begin accepting PA requests on September 24, 2024, for dates of service October 1, 2024, and after. For procedures scheduled to begin on or after October 1, 2024, care providers must contact Carelon Medical Benefits Management to obtain PA for the non‑emergency modalities below. Refer to the clinical guidelines on the microsite resource pages for complete code lists. To determine if PA is needed for a member on or after October 1, 2024, call Provider Services using the phone number on the back of the member’s ID card. Care providers using the interactive care reviewer (ICR) tool on Availity.com for PA requests on an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management (Note: ICR cannot accept PA requests for services administered by Carelon Medical Benefits Management). How to place a review requestCare providers may place a PA request online to Carelon Medical Benefits Management by way of providerportal.com. ProviderPortalSM is available 24/7, processing requests in real-time using clinical criteria. For more informationFor resources to help your practice get started with the cardiology, musculoskeletal, surgical, and programs, visit: Our website helps you access information and tools such as order entry checklists, Clinical Guidelines, and FAQ. Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-063123-24-CPN62818 2024 surveysEach year, Anthem and other health plans in California conduct provider appointment availability (PAAS) and after-hours surveys. These surveys are administered to randomly selected network providers. The PAAS survey helps measure if members can secure appointments within the timeframes mandated by the Department of Managed Health Care (DMHC) and the California Department of Insurance (CDI). The after-hours survey measures providers’ compliance with emergency and after-hours service availability standards. The 2024 PAAS, currently in process, is administered by Anthem’s contracted vendor, Sutherland Healthcare Solutions. They will conduct the 2024 PAAS and after-hours surveys from July 1 through December 31, 2024. Understanding how to complyIf Sutherland Healthcare Solutions contacts your office (via fax, email, or telephone) for a survey about urgent and non-urgent appointment availability, refer to the charts that follow for specific standards: - Compliant — The provider offers an appointment within the required appointment timeframes.
- Non-compliant — The provider fails to offer an appointment within any of the required timeframes or refuses survey participation, leading to a Corrective Action Plan by Anthem.
- The next available appointment date and time can be either in-person or by telehealth services.
Please review and share the following access standards tables that follow with your team. Access standards for medical professionals and ancillary providers |
Non-urgent primary care (PCP) | 10 business days | Non-urgent specialist physician (SCP) | 15 business days | Non-urgent appointment for ancillary services (for diagnosis or treatment of injury, illness, or other health condition) | 15 business days | Urgent care (not requiring prior authorization) | 48 hours | Urgent care (requires prior authorization) (SCP)Urgent Care (requiring prior authorization) | 96 hours |
Access standards for behavioral health and EAP providers Appointment type | Maximum wait time after appointment request | Non-life-threatening emergency care | 6 hours Direct members to 911 or nearest emergency room | Urgent care (not requiring prior authorization) | 48 hours | Urgent care (requires prior authorization) | 96 hours | Routine office visit/non-urgent appointment | 10 business days (psychiatrists)* 10 business days (non-physician mental healthcare providers/substance use disorder) 10 business days from the prior appointment for those undergoing a course of treatment (non-physician mental healthcare/substance use disorder) 5 business days (EAP) |
* The DMHC timely access standard is 15 business days for psychiatrists; however, to comply with the NCQA accreditation standard of 10 business days, Anthem uses the more stringent standard. Access standards for after-hours Emergency care Anthem expects every provider to instruct their after-hours answering service staff that if the caller is experiencing an emergency, instruct the caller to dial 911 or to go directly to the emergency room. Answering machine instructions must also direct the member to call 911 or go to the emergency room if the caller is experiencing an emergency. | Direct members to dial 911 or go to the nearest emergency room. | Urgent requests | Available 24 hours/7days. Member to reach a recorded message or live voice response providing emergency instructions; and for non-emergent (urgent) matters a mechanism to reach a medical professional, or a practitioner (non-MD) with information as to when to expect a call back. |
- Only appropriately qualified staff such as a physician, physician assistant, nurse practitioner, or registered nurse may provide triage or screening clinical advice.
- Interpreter services are coordinated by Anthem or its delegated network provider or other delegated entity with scheduled appointments for healthcare services in a manner that ensures the provision of interpreter services at the time of the appointment without imposing a delay in scheduling the appointment. Anthem requires providers and provider office staff to document members’ request, acceptance, or refusal of interpreter services in the medical record.
- Referrals to a specialist by a primary care provider or another specialist must meet applicable timely access standards.
In 2023 DMHC expanded the list of physicians and service type providers in the PAAS. The table below identifies an updated list of these providers. Primary care and non-physician mental health care providers | Specialist physicians | PCPs | Cardiovascular disease and pediatric cardiology | Non-physician medical practitioners providing primary care | Dermatology and pediatric dermatology | Non-Physician Mental Health Care (NPMH) Providers | Endocrinology and pediatric endocrinology | Licensed professional clinical counselor (LPCC) | Gastroenterology and pediatric gastroenterology | Psychologist (PhD-level) | Epilepsy, neurology, and pediatric neurology | Marriage and family therapist | Oncology and pediatric hematology/oncology | Licensed marriage and family therapist | Ophthalmology | Master of social work | Otolaryngology and pediatric otolaryngology | Licensed clinical social worker | Pediatric pulmonology and pulmonology | Urology and pediatric urology | Mammogram | Psychiatrists, who practice in one or more of the following specialties or subspecialties: psychiatry (addiction, child, adolescent, geriatric) | Physical therapy | |
Keeping you informedSB 221 introduced new legislation beginning January 1, 2023, which created requirements for a referral to a specialist by a primary care or another specialist provider to comply with the required timeframe standards. Why is this important?Anthem is required by law to gather network appointment availability information from our providers to ensure members receive appointments within specific timeframes. We are regulated by the DMHC and CDI to monitor our provider network for prompt access to care and corrective action is taken if standards are not met or when providers refuse to participate in the survey. In certain circumstances, time-elapsed requirements may not be met, and Anthem recognizes these exceptions: - Extending appointment wait time: The applicable waiting time for a particular appointment may be extended if the referring or treating licensed health care provider, or the health professional providing triage or screening services, as applicable, acting within the scope of his or her practice and consistent with professionally recognized standards of practice, has determined and noted in the relevant record that a longer waiting time will not have a detrimental impact on the health of the patient.
- Preventive care services and periodic follow-up care: Preventive care services and periodic follow‑up care are not subject to the appointment availability standards. These services may be scheduled in advance consistent with professionally recognized standards of practice as determined by the treating licensed health care provider acting within the scope of his or her practice. Periodic follow-up care includes but is not limited to, standing referrals to specialists for chronic conditions, periodic office visits to monitor and treat pregnancy, cardiac or mental health conditions, and laboratory and radiological monitoring for recurrence of disease.
- Advanced access: The primary care appointment availability standard may be met if the PCP’s office provides advanced access. Advanced access means offering an appointment to a patient with a PCP (or nurse practitioner or physician’s assistant) within the same or next business day from the time an appointment is requested (or a later date if the patient prefers not to accept the appointment offered within the same or next business day). Note: This exception does not apply to commercial behavioral health.
24/7 NurseLine gives peace of mindAnthem members can access our 24/7 NurseLine, to get advice from a registered nurse anytime. The toll-free phone number is listed on the back of the member ID card and the wait time cannot exceed 30 minutes. Help is a phone call awayFor general questions or need help with referrals, please call the toll-free phone number on the back of the member ID card to speak with the member services team. Representatives are available within 10 minutes during normal business hours. For patients with DMHC-regulated health plansIf you or your patients cannot obtain a timely referral to an appropriate provider or for more information about the regulations, visit the DMHC website at dmhc.ca.gov or call toll-free 888‑466‑2219 for help. For patients with CDI-regulated health plansIf you or your patients cannot obtain a timely referral to an appropriate provider or for more information about the regulations, visit the CDI website at insurance.ca.gov or call toll-free 800‑927‑4357 for help. Language assistance programFor members whose primary language is not English, Anthem offers free, language assistance services through interpreters and other written languages. If you or the member is interested in these services, please call the member services number listed on the member ID card for help (TTY/TDD: 711). QuestionsIf you have questions about this communication, contact your assigned provider relationship management representative or visit anthem.com/ca/provider/contact-us for additional contact information. We hope this clarifies Anthem’s expectations and your obligations regarding compliance with timely access to care regulations and the importance of survey participation. Let us work together to meet the requirements with the least difficulty and member abrasion. Achieving compliance is possible with your participation as our valued network provider. We share a health vision with our care providers that means real change for consumers. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-062801-24, CABC-CM-072859-24 Did you know your Anthem patients can access no cost internet based cognitive behavioral therapy (iCBT) programs online 24/7? The programs help with: - Resilience
- Stress, Anxiety & Worry
- Social Anxiety
- Depression
- Insomnia
- Substance Use
- Panic
Improve equity and access to Mental Health Programs and services for your patients with Learn to Live. Here are some important tips to share with patients so they get the most out of it. The self-directed programs are confidential and convenient. Learn to Live is accessible via a web browser or the app. Members can use the programs anytime - day or night. Stick with itResearch shows the most significant improvement is seen after completing three or more lessons. In the first few lessons members may still be figuring out their goals, learning about iCBT, and learning basic tools. The more lessons they complete, the more likely they'll stick with it and feel improvement. Work with a coachOne of the best ways to maximize the benefits of a Learn to Live program is to work with a personal coach. And it’s free! Users who work with a coach see 44% more improvement compared to those who go it alone. Live and on-demand webinarsLearn to Live creates webinars on a wide variety of topics. They can be accessed on-demand for convenience. Watching webinars is an easy way for members to learn about mental health topics from experts. Encourage your patients to check out our online mental health programs! Available at no cost to members, ages 13+ To access, patients should visit: www.learntolive.com/welcome/CAAnthem and enter code: CAAnthem Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-059973-24-CPN59137 We are thrilled to announce the upcoming launch of Payment Integrity's new innovative tool, the Provider e-Learning Resource Center (PeRC). This is an exciting upgrade exemplary of our ongoing commitment to providing the best resources for your billing and coding success. PeRC is an educational platform: - Dedicated to accurate coding initiatives, with the goal of resulting in reduced errors.
- That promotes a well-informed care provider community, enhances healthcare services, and improves outcomes.
Stay tuned for the official launch date and more details about the Provider e-Learning Resource Center from the Provider Education team. We are committed to a future of shared success. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCRCM-061010-24-CPN60941 On August 6, 2011, the U.S. Breastfeeding Committee (USBC) officially declared August as National Breastfeeding Month.1 In recognition of August as National Breastfeeding Month, we are introducing resources published by numerous trusted sources, including My Diverse Patients. The first is an eLearning experience, developed for care providers, nurses, office staff, and other healthcare professionals. It is titled Promoting Birth Equity. You can find it on the Maternal Health Disparities page. In addition, within the Current Trends section, we offer access to an education resource via an externally published special series called Lost Mothers: Maternal Mortality In The U.S. It includes a resource by the National Public Radio entitled Black Mothers Keep Dying After Giving Birth. Shalon Irving's Story Explains Why. Further and in accordance, the U.S. Centers for Disease Control and Prevention (CDC) offers these key points about breastfeeding: - Breastfeeding is the best source of nutrition for most infants.
- Breastfeeding can reduce the risk of certain health conditions for both infants and mothers.
- Only one in four infants are exclusively breastfed as recommended until they are six months old.
- CDC supports and promotes breastfeeding across the United States.
Infants who are breastfed and mothers who breastfeed have reduced risk of: - Asthma and severe lower respiratory disease.
- Obesity.
- Type 1 diabetes.
- Acute otitis media (ear infections).
- Sudden infant death syndrome (SIDS).
- Gastrointestinal infections, which can cause diarrhea and vomiting.
- Necrotizing enterocolitis (NEC) (death of intestinal tissue) for preterm infants.
Mothers who breastfeed also have reduced risk of high blood pressure, Type 2 diabetes, ovarian cancer, and breast cancer.2 Whole healthWe are taking a holistic view that can transform health. Maternal-child health includes the entire pre‑pregnancy, pregnancy, delivery, and postpartum journey of a parent and child up to one year after birth.3 Healthy babies start with healthy pregnancies. The United States has a robust healthcare infrastructure, spending more per capita on healthcare than any other nation, but maternal health in the U.S. has lagged behind that of other developed countries.4 Certified doula care can help improve maternal and infant health outcomesResearch shows that doulas — trained professionals who counsel pregnant people before, during, and after their babies are born — can help improve maternal health outcomes by offering information and education, as well as physical, social, and emotional support. Such care has been found to reduce the rate of cesarean births, preterm births, and postpartum depression, while also improving breastfeeding rate.4 We look forward to working together to deliver high-quality, equitable healthcare. If you have any questions about this communication, visit the Contact Us section of our provider website. - National Breastfeeding Month. U.S. Breastfeeding Committee. (n.d.). https://www.usbreastfeeding.org/national-breastfeeding-month.html
- Centers for Disease Control and Prevention. (2023, December 18). About breastfeeding. Centers for Disease Control and Prevention. https://www.cdc.gov/breastfeeding/php/about/index.html
- Maternal Health. Elevance Health. (n.d.). https://www.elevancehealth.com/our-approach-to-health/maternal-health
- Elevance Health Impact. (2023, April 30). Certified Doula Care Can Help Improve Maternal and Infant Health Outcomes Video. Elevance Health. https://www.elevancehealth.com/our-approach-to-health/whole-health/certified-doula-care-can-help-improve-maternal-and-infant-health-outcomes
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. MULTI-ALL-CDCRCM-062151-24-CPN61848 Participating providers are responsible for offering members access to covered services 24/7. Access includes regular office hours on weekdays and the availability of a provider or designated agent by telephone after regular office hours, on weekends, and on holidays. When unavailable, providers must arrange for on-call coverage by another participating provider. Providers are also required to meet appointment access standards as described below. After-hours calls:- Providers must instruct their after-hours answering service to answer Anthem’s After Hours Survey questions. Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract.
- The answering service or after-hours personnel must ask the member if the call is an emergency. In the event of an emergency, the member must be immediately directed to dial 911 or to proceed directly to the nearest hospital emergency room.
- If staff or answering service is not immediately available, an answering machine may be used. The answering machine message must instruct members with emergency healthcare needs to dial 911 or go directly to the nearest hospital emergency room. The message must also give members an alternative contact number so they can reach the primary care physician (PCP) or on-call provider with medical concerns or questions.
- Non-English-speaking members who call their PCP after hours should expect to get language-appropriate messages. In the event of an emergency, these messages should direct the member to dial 911 or proceed directly to the nearest hospital emergency room.
- In a non-emergency situation, members should receive instruction on how to contact the on-call provider. If an answering service is used, the service should know where to contact a telephone interpreter. All calls taken by an answering service must be returned.
Appointment accessNote: The next available appointment date and time can be either in person or by telehealth services. Healthcare providers must make appointments for members from the time of request as follows: General appointment scheduling | | Emergency examination | Immediate access, 24/7 | Urgent (sick) examination | Within 48 hours of request if authorization is not required or within 96 hours of request if authorization is required, or as clinically indicated (New this year: These timeframes include weekends and holidays.) | Routine primary care examination (non-urgent) | Within 10 business days of request | Non-urgent consults/specialty referrals | Within 15 business days of request | Non-urgent care with non-physician mental health provider or substance use disorder (SUD) provider (where applicable) | Within 10 business days of request | Non-urgent follow-up care with non-physician mental health provider or SUD provider | Within 10 business days of request | Non-urgent ancillary | Within 15 business days of request | Mental health appointment, non-physician | Within 10 business days of request |
SB221 — As of July 1, 2022, non-physician mental health/SUD appointments are subject to the timely access standards outlined in the chart above. This bill also requires that all health plans ensure that enrollees who are undergoing a course of treatment for an ongoing mental health or SUD condition can schedule a follow-up appointment with their non-physician mental healthcare or SUD provider within 10 business days of the prior appointment. Services for members under the age of 21 years | Initial health assessments | | Children from birth to 20 years of age | Within 120 days of enrollment | Preventive care visits | Within 14 days of request | |
Initial health assessments | Within 120 days of enrollment | Preventive care visits | Within 14 days of request | Routine physicals | Within 30 days of request | |
First and second trimester | Within seven days of request | Third trimester | Within three days of request | High-risk pregnancy | Within three days of identification | Postpartum | Between 7 and 84 days after delivery | |
Skilled nursing facility | - Rural and small counties — within 14 business days of request
| | - Medium counties — within seven business days of request
- Dense counties — within five business days of request
| Intermediate care facility/developmentally disabled (ICF- DD) | - Rural and small counties — within 14 business days of request
- Medium counties — within seven business days of request
- Dense counties — within five business days of request
| Community-based adult services (CBAS) | Capacity cannot decrease in aggregate statewide below April 2021 level |
SpecialistsThe following guidelines are in place for our specialists: - For urgent care, the specialist should see the member within 96 hours of receiving the request.
- For routine care, the specialist should see the member within 15 business days of receiving the request.
- A copy of the medical records and/or results of the visit should be sent to the PCP’s office to allow continuity of care.
Wait timesWhen a provider's office receives a call from an Anthem member during regular business hours — as well as after-hours — for assistance and possible triage, the provider or another healthcare professional must either take the call or call the member back within 30 minutes of the initial call. When an Anthem member arrives on time to an appointment, the member should be seen within 15 minutes of the scheduled appointment. When Anthem members and/or prospective members call a physician’s office, they should not be placed on hold for longer than 10 minutes. Interpretation servicesWhen a provider’s office receives a call from an Anthem member, the provider’s office should know where to contact a telephone interpreter to communicate in the member’s preferred language. NoncomplianceEnsure that you comply with the standards described; compliance with these standards is a contractual requirement. Anthem monitors compliance through a number of mechanisms, including annual telephonic surveys, to determine if participating provider offices meet the above standards. For additional details, review the provider manuals on our website. As of 2023, delegated network providers are measured based on a compliance threshold of 70% as outlined in CCR 1300.67.2.2. Delegates scoring below 70% compliance for Non-Urgent and Urgent appointment availability will be subject to corrective action, up to and including, termination of the contract. Required timely access training course — to be released in measurement year 2024 Rescheduling missed appointments — Los Angeles county providers only Missed appointments | Standard | The time after a missed appointment that a patient is contacted to reschedule their appointment | 48 hours |
This is a reminder that Los Angeles county providers are required to call to reschedule an appointment within 48 hours after a missed appointment. Ensure your office’s policies and procedures and training are updated to include this requirement. Providers may be surveyed on a random sample to ensure compliance with this standard. Schedule of timely access surveysProvider Appointment Availability Survey (PAAS): - Survey subject(s): appointment availability
- Managed Care Plan: Anthem
- Contractor conducting survey: Sutherland
- Regulatory agency: Department of Managed Health Care (DMHC)
- Schedule: July through November 2024
After Hours and Appointment Availability Survey: - Survey subject(s): emergency and urgent after-hours calls
- Managed Care Plan: Anthem
- Contractor conducting survey: TBD
- Regulatory agency: National Committee for Quality Assurance (NCQA); DMHC
- Schedule: October through November 2024
Primary Care and Specialty Care Appointment Availability Survey: - Survey subject(s): appointment availability, interpretation services
- Conducting/regulatory agency: Department of Health Care Services (DHCS)
- Schedule:
- Q1: January through March
- Q2: April through June
- Q3: July through September
- Q4: October through December
DHCS administers the surveys and Anthem is provided the surveys after each quarter. Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-063209-24-SRS63167 Per APL 23-020, Anthem will pay all claims within contractually mandated statutory timeframes and in accordance with the timely payment standards in the Contract for clean claims within 45 working days of receipt. If Anthem does not pay a clean claim within 45 working days of receipt, Anthem will owe the provider interest at the rate of 15% per annum beginning on the first day after a period of 45 working days. For additional information, see the provider manuals at the link below. References:
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-062457-24 Effective August 12, 2024 Summary: On May 17, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. If you have questions or for additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note:- The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | August 12, 2024 | *CC-0262 | Tevimbra (tislelizumab-jsgr) | New | August 12, 2024 | *CC-0162 | Tepezza (teprotumumab-trbw) | Revised | August 12, 2024 | *CC-0111 | Nplate (romiplostim) | Revised | August 12, 2024 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | August 12, 2024 | *CC-0002 | Colony Stimulating Factor Agents | Revised | August 12, 2024 | CC-0128 | Tecentriq (atezolizumab) | Revised | August 12, 2024 | *CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | August 12, 2024 | *CC-0101 | Torisel (temsirolimus) | Revised | August 12, 2024 | *CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | August 12, 2024 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | August 12, 2024 | *CC-0092 | Adcetris (brentuximab vedotin) | Revised | August 12, 2024 | CC-0106 | Erbitux (cetuximab) | Revised | August 12, 2024 | *CC-0105 | Vectibix (panitumumab) | Revised | August 12, 2024 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | August 12, 2024 | CC-0160 | Vyepti (eptinezumab) | Revised | August 12, 2024 | CC-0102 | GNRH Analogs for Oncologic Indications | Revised | August 12, 2024 | CC-0201 | Rybrevant (amivantamab-ymjw) | Revised | August 12, 2024 | *CC-0188 | Imcivree (setmelanotide) | Revised | August 12, 2024 | *CC-0124 | Keytruda (pembrolizumab) | Revised | August 12, 2024 | CC-0041 | Complement C5 Inhibitors | Revised | August 12, 2024 | CC-0199 | Empaveli (pegcetacoplan) | Revised | August 12, 2024 | *CC-0130 | Imfinzi (durvalumab) | Revised | August 12, 2024 | CC-0240 | Zynyz (retifanlimab-dlwr) | Revised | August 12, 2024 | CC-0123 | Cyramza (ramucirumab) | Revised | August 12, 2024 | CC-0187 | Breyanzi (lisocabtagene maraleucel) | Revised | August 12, 2024 | CC-0158 | Enhertu (fam-trastuzumab deruxtecan-nxki) | Revised | August 12, 2024 | CC-0226 | Elahere (mirvetuximab) | Revised | August 12, 2024 | CC-0043 | Monoclonal Antibodies to Interleukin-5 | Revised | August 12, 2024 | *CC-0066 | Monoclonal Antibodies to Interleukin-6 | Revised | August 12, 2024 | CC-0221 | Spevigo (spesolimab-sbzo) | Revised | August 12, 2024 | CC-0071 | Entyvio (vedolizumab) | Revised | August 12, 2024 | *CC-0063 | Ustekinumab Agents | Revised |
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-061712-24-CPN61521 This article was updated as of August 23, 2024. Effective on October 20, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates for medical necessity review, will apply for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. This does not equate to the presence of a prior authorization requirement. In the event a prior authorization requirement for these services will be implemented, a separate notice will be distributed before the addition of any prior authorization requirements. - Cardiology:
- Cardiac Resynchronization Therapy
- Endovascular Revascularization
- Imaging of the Heart
- Implantable Cardioverter Defibrillators
- Percutaneous Coronary Intervention
- Permanent Implantable Pacemakers
- Genetic Testing:
- Pharmacogenomic Testing
- Predictive and Prognostic Polygenic Testing
- Chromosomal Microarray Analysis
- Whole Exome Sequencing and Whole Genome Sequencing
- Somatic Tumor Testing
- Musculoskeletal:
- Spine Surgery
- Sacroiliac Joint Fusion
- Radiology:
- Imaging of the Spine
- Imaging of the Extremities
- Vascular Imaging
- Imaging of the Brain
- Sleep:
- Sleep Disorder Management
Please share this notice with other members of your practice and office staff. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-056096-24-CPN54674, MULTI-ALL-CDCR-066707-24 This article was updated as of September 4, 2024. Effective November 1, 2024, Anthem will use MCG B-806-T (Behavioral Health Care [BHG] Applied Behavioral Analysis (Original MCG Guideline) for medical necessity and clinical appropriateness reviews. If you have questions, contact the Provider Services number on the back of the member's ID card. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-060017-24-CPN46739, CABC-CD-066151-24 Effective September 1, 2024, Anthem will upgrade to the 28th edition of MCG Care Guidelines. Along with this upgrade, there will be some changes as to how transcranial magnetic stimulation (TMS) will be approved. A specific change will be noted for Behavioral Health Care (BHG): Transcranial Magnetic Stimulation B-801-T. An annotation for motor threshold redetermination after initiation of treatment has been added to the Inconclusive or non-supportive evidence section of the evidence summary with new references to support it. Any requests for CPT® code 90869 will be referred for peer clinical review to determine medical necessity. If you have questions, please contact Provider Services by calling the number on the back of the member's ID card. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BC-CM-062339-24-SRS62339 Effective for dates of service on and after April 14, 2024, the following updates will apply to the Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines. As part of the Carelon Medical Benefits Management guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services. Radiation Oncology:- IMRT for Colon Cancer
- New indication for adjuvant treatment of locally advanced adenocarcinoma of the cecum.
- SBRT for Hepatocellular Carcinoma
- Modify eligibility criteria to match clinical trial RTOG 1112
- EBRT/IMRT for Prostate Cancer
- Adjust for 2 Gy fractions. The total allowed dosage is the same with each fraction is a little larger (now 2 Gy) and lower number of fractions.
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management using the following: - Access Carelon Medical Benefits Management’s provider portal directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-061951-24-CPN61879 Effective for dates of service on and after November 17, 2024, the following updates will apply to the Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines. As part of the Carelon Medical Benefits Management guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services. Genetic testingCell-free DNA Testing (Liquid Biopsy) for the Management of Cancer: - Expanded criteria to include a wider scope of testing for metastatic disease: AKT1 and PTEN (related to capivasertib/fulvestrant therapy)
Prenatal Testing [changed to Screening] using cell-free DNA: - Expanded criteria to include follow-up screening for abnormal maternal serum screen results in viable singleton/twin pregnancies when diagnostic testing is declined
- Expanded criteria to include screening for pregnancies with multiple anomalies when diagnostic testing is not possible
Somatic Testing of Solid Tumors: - Tissue-agnostic testing for patients with advanced solid tumors:
- Clarification about TMB testing by FDA-approved test with reporting threshold ≥ 10 mutations/megabase (mut/Mb)
- Bladder cancer:
- Expansive changes for microsatellite instability/mismatch repair deficiency (MSI/dMMR)
- Brain cancer:
- New clinical criteria considered clarifications for what may have otherwise been reviewed using general (umbrella) criteria
- Breast cancer, metastatic:
- Expanded criteria to include a wider scope of testing for metastatic disease: AKT1 and PTEN (related to capivasertib/fulvestrant therapy)
- Colorectal cancer, localized and metastatic:
- Newly diagnosed localized or metastatic CRC — Expanded criteria for MSI/dMMR testing to allow in individuals with de novo metastatic disease
- Metastatic CRC — Expanded POLE/POLD1 testing
- Endometrial carcinoma:
- Expanded routine testing for MSI/dMMR; also expanded POLE and p53 testing
- Panel size limited to ≤ 50 genes
- Non-small cell lung cancer, metastatic:
- New criteria for metastatic squamous cell carcinoma
- Allowance for repeat NGS testing in the setting of progressive disease, if a progressing lesion is being used for the repeat testing
- Ovarian (epithelial):
- Added statement that HRD testing must include evaluation of genomic instability through an FDA approved test
- Pancreatic adenocarcinoma:
- Added criteria for targeted (50 or fewer genes) somatic testing beyond MSI/dMMR in locally advanced, metastatic, or recurrent pancreatic adenocarcinoma
- Prostate cancer, metastatic:
- Specified appropriateness of MSI/dMMR testing is in metastatic prostate cancer
- Moved ATM from required to "may be included" genes in approvable NGS panels
- Thyroid cancer:
- Testing of indeterminate thyroid nodules (ITN) — Afirma GSC added as a gene expression classifier that may be used
- Somatic testing of thyroid malignancy — Modified language so that BRAF V600E, ALK, NTRK, and RET testing can be done in anaplastic thyroid cancer at any stage, or in unresectable, locally advanced, recurrent, or metastatic thyroid cancer
Somatic Testing of Hematologic Malignancies: - Acute Lymphocytic Leukemia:
- Added statement about NGS testing on bone marrow specimen which specifies time points where testing is appropriate (such as, end of initial induction, end of initial consolidation)
- Acute Myelogenous Leukemia:
- Added an indication for focused testing using RT-qPCR to measure minimal residual disease (MRD)
- Chronic Myeloid Leukemia:
- Modified the timing for BCR-ABL1 quantification for monitoring in the first year after completion of tyrosine kinase inhibitor (TKI) therapy
- Added allowance for BCR-ABL1 quantification for monitoring patients at three-month intervals beyond one year after completion of TKI therapy
- Myeloproliferative Neoplasms:
- Added allowance for additional focused testing for initial risk stratification if a specific myeloproliferative neoplasm is diagnosed on initial diagnostic workup
- Myelodysplastic Syndrome:
- Clarified that testing can be pursued for diagnosis or risk stratification and clarified the list of genes that may be associated with MDS
MusculoskeletalJoint Surgery: - Reverse Shoulder Arthroplasty:
- Added a requirement for impaired function for six months for consistency with total shoulder arthroplasty
- Removed requirement for conservative management when there is severe osteoarthritis for consistency with other joint replacements
- Shoulder Arthroscopy and Open Procedures:
- Removal of loose body — Removed requirement for specific findings on exam
- Rotator cuff repair and revision — Added an exclusion for subacromial balloon spacer due to lack of supporting evidence
- Labrum Repair — Removed Bankart lesion broadening MRI findings to allow for any labral tear
- Chronic shoulder instability or laxity — Broadened exam findings to include any evidence of instability rather than just the apprehension/relocation test
- Tendinopathy of the long head of the biceps — Removed specific exam findings related to long head of biceps pathology
- Primary Total Hip Arthroplasty:
- Removed the requirements for conservative management and three-month duration of symptoms when radiographs show severe osteoarthritis
- Primary Partial Hip Arthroplasty:
- Combined criteria for partial hip arthroplasty and partial hip resurfacing
- Hip Arthroscopy:
- Removal of loose body — Removed requirement for specific findings on exam
- Knee Arthroplasty:
- Added exclusion for the use of an implantable shock absorber due to lack of supporting evidence
- Knee Arthroscopy:
- ACL reconstruction — Removed standalone scenario of physically demanding occupation/pattern of activities
- Excision of popliteal cyst — Added imaging requirement
- Repair of subchondral bone defects (subchondroplasty) — Added exclusion for use of engineered calcium phosphate mineral or similar compounds due to lack of supporting evidence
- Osteochondral Grafts:
- Juvenile Osteochondritis Dissecans — Expanded allowances to include either failed conservative management or unstable lesion
- Added exclusion for use of particulated juvenile articular cartilage due to lack of evidence supporting its use
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management using the following: - Access Carelon Medical Benefits Management’s provider portal directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-061749-24-CPN61577 This article was updated as of September 11, 2024. The Medical Policies, Clinical Utilization Management (UM) Guidelines and Third-Party Criteria below were developed and/or revised during Quarter 1, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications or criteria and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit providers.anthem.com/ca > Resources > Provider Manuals, Policies & Guidelines > Medical Policies and Clinical UM Guidelines. Notes/Updates:Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive. - LAB.00039 - Combined Pathogen Identification and Drug Resistance Testing; Previously Titled: Pooled Antibiotic Sensitivity Testing
- Revised title
- Revised Position Statement to address “combined pathogen identification and drug resistance” testing
- OR-PR.00008 - Osseointegrated Limb Prostheses
- Outlines the Medically Necessary and Not Medically Necessary criteria for the use of osseointegrated (bone-anchored) prosthetic devices for improving the mobility and function of people who have had limb loss
- SURG.00052 - Percutaneous Vertebral Disc and Vertebral Endplate Procedures
- Revised Medically Necessary criteria for basivertebral nerve ablation (BVNA)
- SURG.00162 - Implantable Shock Absorber for Treatment of Knee Osteoarthritis
- Use of an implantable shock absorber device for treatment of osteoarthritis of the knee is considered Investigational & Not Medically Necessary
- CG-DME-53 - Biomechanical Footwear Therapy
- Biomechanical footwear therapy is considered Not Medically Necessary for all indications
- CG-LAB-32 - Cancer Antigen 125 Testing
- Outlines the Medically Necessary and Not Medically Necessary criteria for the tumor marker cancer antigen 125 (CA-125) testing
- CG-MED-94 - Vestibular Function Testing
- Revised Medically Necessary and Not Medically Necessary statements to include vestibular-evoked myogenic potential tests
- CG-MED-96 - Prefabricated External Infant Ear Molding Systems
- Outlines the Medically Necessary, Reconstructive and Cosmetic & Not Medically Necessary criteria for the use of prefabricated external infant ear molding systems to treat external ear malformations and deformations
Medical PoliciesOn February 15, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect August 8, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 4/10/2024 | *LAB.00039 | Combined Pathogen Identification and Drug Resistance Testing Previously Titled: Pooled Antibiotic Sensitivity Testing | Revised | 2/22/2024 | MED.00140 | Gene Therapy for Beta Thalassemia | Revised | 4/10/2024 | *OR-PR.00008 | Osseointegrated Limb Prostheses | New | 4/1/2024 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Revised | 4/10/2024 | *SURG.00052 | Percutaneous Vertebral Disc and Vertebral Endplate Procedures | Revised | 4/10/2024 | SURG.00145 | Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts) | Revised | 4/10/2024 | *SURG.00162 | Implantable Shock Absorber for Treatment of Knee Osteoarthritis | New | 4/10/2024 | TRANS.00028 | Hematopoietic Stem Cell Transplantation for Hodgkin Disease and non-Hodgkin Lymphoma | Revised |
Clinical UM GuidelinesOn February 15, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicare members on March 28, 2024. These guidelines take effect August 8, 2024. Publish Date | Clinical UM Guideline Number | Clinical UM Guideline Title | New or Revised | 4/10/2024 | CG-DME-50 | Automated Insulin Delivery Systems | Revised | 4/10/2024 | *CG-DME-53 | Biomechanical Footwear Therapy | New | 4/10/2024 | *CG-LAB-32 | Cancer Antigen 125 Testing | New | 4/10/2024 | CG-MED-68 | Therapeutic Apheresis | Revised | 4/10/2024 | *CG-MED-94 | Vestibular Function Testing | Revised | 4/10/2024 | *CG-MED-96 | Prefabricated External Infant Ear Molding Systems | New | 4/10/2024 | CG-SURG-118 | Intraocular Anterior Segment Aqueous Drainage Devices (without extraocular reservoir) | Conversion New | 4/10/2024 | CG-SURG-119 | Treatment of Varicose Veins (Lower Extremities) | Conversion New | 4/10/2024 | CG-SURG-120 | Vagus Nerve Stimulation | Conversion New | 4/10/2024 | CG-SURG-121 | Fetal Surgery for Prenatally Diagnosed Malformations | Conversion New | 4/1/2024 | CG-SURG-78 | Locoregional Techniques for Treating Primary and Metastatic Liver Malignancies | Revised |
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-061524-24-CPN60990, MULTI-ALL-CRMMP-066285-24 Effective October 1, 2024 Effective October 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medi-Cal Managed Care members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control |
To request PA, you may use one of the following methods: - Web: Once logged in to Availity Essentials at Availity.com.
- Fax: 800-754-4708
- Phone:
- Medi-Cal: 888-831-2246
- MRMIP: 877-273-4193
Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/ca on the Resources tab or for contracted providers by accessing Availity.com. For assistance with PA requirements, providers may also call Provider Services at 800-407-4627 outside of Los Angeles County, and 888-258-7801 within Los Angeles County. UM AROW A2024M1495 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-059736-24-CPN59021 (Policy G-06016, effective 07/01/2024) Past system limitations prevented us from reimbursing Modifier 78 in complete alignment with Centers for Medicare & Medicaid Services (CMS). New system updates will now allow Anthem to closer align with the CMS Medicare Physician Fee Schedule Data Base (MPFSDB). For claims processed on and after 07/01/2024, you may see a slight adjustment in reimbursement which will reflect this configuration update. For additional information, please review the Modifier 78 reimbursement policy at anthem.com/ca/provider/medicare-advantage. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-048993-23-CPN45239 (Policy G-20002, effective 11/01/2024) Beginning with dates of service on or after 11/01/2024 Anthem will update the Nurse Practitioner and Physician Assistant Services reimbursement policy as indicated below. The following services will be removed as physicians’ services: - Preventive Services
- Radiology Services
The following services will be included as physicians’ services: - Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS)
- Laboratory Services and Screening Services
For additional information, please review the Nurse Practitioner and Physician Assistant Services reimbursement policy for Medicaid: providers.anthem.com/ca or for Medicare: anthem.com/ca/provider/medicare-advantage. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCR-050408-24-CPN49984 Effective November 1, 2024, the following medication codes will require prior authorization. Please note, inclusion of a National Drug Code (NDC) on your medical claim is necessary for claims processing. Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below. Clinical Criteria | HCPCS or CPT® code(s) | Drug name | CC-0252 | C9399, J3590 | Adzynma (ADAMTS13, recombinant-krhn) | CC-0253 | J3490, J3590, J9999 | Aphexda (motixafortide) | CC-0107 | J3490, J3590 | Avzivi (bevacizumab-tnjn) | CC-0042 | C9399, J3490 | Bimzelx (bimekizumab-bkzx) | CC-0032 | J0589 | Daxxify (daxibotulinumtoxinA-lanm) | CC-0059 | J3490 | Focinvez (fosaprepitant) | CC-0255 | C9399, J3490, J3590 | Loqtorzi (toripalimab-tpzi) | CC-0050 | J3590 | Omvoh (mirikizumab-mrkz) | CC-0256 | J3490 | Rivfloza (nedosiran) | CC-0002 | J3490, J3590 | Ryzneuta (efbemalenograstim alfa-vuxw) | CC-0066 | J3490, J3590 | Tofidence (tocilizumab-bavi) | CC-0257 | C9399, J3490 | Wainua (eplontersen) | CC-0254 | J3490 | Zilbrysq (zilucoplan) | CC-0062 | J3590 | Zymfentra (infliximab-dyyb) |
What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at: - Outside Los Angeles County: 800-407-4627
- Los Angeles County: 888-285-7801
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-059334-24-CPN58839 |